Hunt Jr., a one-time Wilson County farm boy who rose to become one of the dominant figures in 20th-century North Carolina ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...

For the better part of a year, Merck & Co. and Halozyme have been locked in an intellectual property disagreement over the the pharma giant's new, under-the-skin version of cancer megablockbuster ...

Germany's Merck KGaA is looking at making further acquisitions to boost its business, according to chief executive Belén Garijo. The CEO – who is due to step down next April after five years in the ...

Merck shares began peeling back in early 2024, mostly on concerns about looming patent expirations for its breadwinning drug. The trading crowd changed its collective mind a couple months ago, sending ...

Halozyme HALO3.44%increase; green up pointing triangle was granted a preliminary injunction that would prevent Merck MRK 0.40%increase; green up pointing triangle & Co. from distributing a formulation ...

Yield, sector focus, and risk profiles set these two dividend ETFs apart—see how their distinct strategies may fit different investor goals.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

The Merck Future Insight prize was established on the occasion of Merck’s 350th anniversary in 2018 to honour and enable pioneering scientists who are striving to solve some of the biggest challenges ...

WILMINGTON, Ohio — Wilmington City Council chambers overflowed Thursday night as dozens of residents voiced concerns about a proposed Amazon data center project in the community about 50 miles ...

U.S. President Donald Trump and nine major pharmaceutical companies on Friday announced deals that will slash the prices of their medicines for the government's Medicaid program and for cash payers, ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...